ASP Isotopes Inc.
ASP Isotopes Inc. (Nasdaq: ASPI) develops isotope-enrichment technologies for materials used in nuclear medicine, pharmaceuticals, agrochemicals, semiconductors and nuclear energy. Its platforms are the Aerodynamic Separation Process and Quantum Enrichment technologies, with initial isotope products including… From the company’s description.
Over the twelve months to Jun 30, 2026, ASP Isotopes Inc. reported revenue of $30.85M, up 573.5% from a year earlier, and a net loss of $117.34M. Its operating margin was −321.1%, and operations used $67.80M in cash. In fiscal 2025, it reported revenue of $23.85M, up 475.5% from fiscal 2024, and a net loss of $159.84M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What ASP Isotopes Inc. does
In the company’s own words
ASP Isotopes Inc. (Nasdaq: ASPI) develops isotope-enrichment technologies for materials used in nuclear medicine, pharmaceuticals, agrochemicals, semiconductors and nuclear energy. Its platforms are the Aerodynamic Separation Process and Quantum Enrichment technologies, with initial isotope products including carbon-14, silicon-28 and ytterbium-176; it also pursues development of nuclear fuels such as high-assay low-enriched uranium and lithium-6. The company operates through three reportable segments: Specialist Isotopes and Related Services, which includes radiopharmaceutical production and distribution through PET Labs; Nuclear Fuels, focused on advanced nuclear fuel development; and Construction Services, which performs public civil engineering work in Hong Kong. In January 2026, ASP Isotopes acquired Renergen, adding natural gas exploration and production, including liquefied natural gas and liquid helium, through South Africa’s Virginia Gas Project. Its isotope facilities include two aerodynamic enrichment plants and a laser-based enrichment facility in Pretoria, South Africa. Its website is https://aspisotopes.com/.
Company details
- Sector
- Materials
- Industry (SIC)
- Chemicals
- Headquarters
- DALLAS, TX
- Fiscal year end
- December
- CIK
- 1921865
- SIC
- 2890
Financial performance, year by year
Fiscal 2022–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns ASP Isotopes Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in ASP Isotopes Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · ASP Isotopes Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do ASP Isotopes Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of ASP Isotopes Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in ASP Isotopes Inc.'s last four quarterly filings that the numbers alone won't show?”